Brilique 60 mg film-coated tablets

DRUG4 trials

Sponsors

Fundacion Biomedica Galicia Sur, Medical University Of Gdansk, Icahn School Of Medicine At Mount Sinai, Nicolaus Copernicus University

Conditions

Acute Coronary Syndrom (ACS)Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary InterventionNew-Onset Post-Operative Atrial Fibrillation after CABGSevere Symptomatic Aortic Stenosis

Phase 3

Evaluation of safety and efficacy of two ticagrelorbased de-escalation antiplatelet strategies in acute coronary syndrome: the randomized, multicenter, double-blind ELECTRA RCT study.

Active, not recruitingCTIS2024-518090-34-00

Nicolaus Copernicus UniversityAcute Coronary Syndrom (ACS)

Start: 2022-02-07Target: 4500Updated: 2024-11-24

Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI)

CompletedCTIS2024-515056-20-00

Medical University Of GdanskAcute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Start: 2021-07-31End: 2025-10-31Target: 2230Updated: 2025-04-01

Phase 4

Single antiplatelet treatment with Ticagrelor or Aspirin after Transcatheter Aortic Valve Implantation: multicenter randomized clinical trial

RecruitingCTIS2023-509290-22-00

Fundacion Biomedica Galicia SurSevere Symptomatic Aortic Stenosis

Start: 2022-01-21Target: 1200Updated: 2025-09-16

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG - PACeS

RecruitingCTIS2024-515924-35-00

Icahn School Of Medicine At Mount SinaiNew-Onset Post-Operative Atrial Fibrillation after CABG

Start: 2023-01-16Target: 750Updated: 2025-06-11